The IOPIMAX brand, founded in 1995 (Switzerland), from 2951 sister brands and 17478 competing brands. The IOPIMAX brand is owned by NOVARTIS N, a company listed in Zurich. The ISIN, the company's International Securities Identification Number, is CH0012005267. IOPIMAX is part of the Drug Manufacturers activity sector.